Tech Company Financing Transactions

Stylus Medicine Funding Round

Stylus Medicine, operating out of Cambridge, scored $85 million in funding from Eli Lilly and Company, Johnson & Johnson Innovation and Khosla Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1400 One Kendall Square 14-403
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.stylusmedicine.com

Email Address

Not Recorded

Overview

Stylus Medicine is developing in vivo genetic medicines to unlock cures. Our platform is powered by engineered recombinases that encode therapeutics with high precision. Our recombinases are designed to recognize a safe harbor site in the human genome and introduce a therapeutic payload with high specificity and integrity.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Emile Nuwaysir

        

Chief Scientific Officer

Jason Fontenot

        

Vice President

Celeste Richardson

        

VP - Bus. Development

Cecilia Sun

        

VP - Engineering

Chris Wilson

        

VP - Finance

Nicole Heifner

        

VP - General Counsel

Nicole Conlon

        

Browse more venture capital transactions:

Prev: 5/13/2025: Somite Therapeutics venture capital transaction
Next: 5/13/2025: Freshr Sustainable Technologies venture capital transaction

Share this article

Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary